| Lasa Supergenerics Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540702 |
NSE Symbol : LASA |
P/E(TTM) : 165.00 |
|
ISIN Demat : INE670X01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.05 |
|
Book Value(₹) : 11.25 |
Market Cap(₹Cr) : 41.33 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 2.20 | 3.06 | 20.01 | 39.14 | 33.08 | 39.39 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2.20 | 3.06 | 20.01 | 39.14 | 33.08 | 39.39 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.02 | 0.01 | 0.13 | 2.39 | 8.91 | 1.95 |
| Total Income | 2.22 | 3.07 | 20.15 | 41.53 | 41.99 | 41.34 |
| Total Expenditure | 2.95 | 7.06 | 41.09 | 59.64 | 32.82 | 38.60 |
| PBIDT | -0.73 | -3.99 | -20.94 | -18.11 | 9.18 | 2.74 |
| Interest | 0.11 | 0.12 | 0.03 | 0.11 | 0.47 | 1.24 |
| PBDT | -0.84 | -4.11 | -20.97 | -18.22 | 8.71 | 1.50 |
| Depreciation | 1.57 | 1.57 | 1.57 | 3.90 | 2.80 | 2.81 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.14 | 0.57 | -1.42 | -7.83 | 0.42 | 1.92 |
| Reported Profit After Tax | -2.55 | -6.25 | -21.12 | -14.29 | 5.49 | -3.23 |
| Extra-ordinary Items | 0.00 | 0.00 | -20.57 | -23.91 | 7.83 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -2.55 | -6.25 | -0.55 | 9.62 | -2.34 | -3.23 |
| EPS (Unit Curr.) | -0.51 | -1.25 | -4.22 | -2.85 | 1.10 | -0.64 |
| EPS (Adj) (Unit Curr.) | -0.51 | -1.25 | -4.22 | -2.85 | 1.10 | -0.64 |
| Calculated EPS (Unit Curr.) | -0.51 | -1.25 | -4.22 | -2.85 | 1.10 | -0.64 |
| Calculated EPS (Adj) (Unit Curr.) | -0.51 | -1.25 | -4.22 | -2.85 | 1.10 | -0.64 |
| Calculated EPS (Ann.) (Unit Curr.) | -2.04 | -4.99 | -16.86 | -11.41 | 4.39 | -2.58 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -2.04 | -4.99 | -16.86 | -11.41 | 4.39 | -2.58 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 50.10 | 50.10 | 50.10 | 50.10 | 50.10 | 50.10 |
| Reserve & Surplus | 0.00 | 6.24 | 0.00 | 0.00 | 0.00 | 40.61 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -33.18 | -130.39 | -104.65 | -46.27 | 27.75 | 6.96 |
| PBDTM(%) | -38.18 | -134.31 | -104.80 | -46.55 | 26.33 | 3.81 |
| PATM(%) | -115.91 | -204.25 | -105.55 | -36.51 | 16.60 | -8.20 |
